New rationale elucidated for clinical evaluation of GW-506U in refractory hematologic malignancies Jan. 9, 1998 No Comments
Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity Jan. 2, 1998 No Comments
Lilly develops compounds for the common cold; selects development candidate Dec. 30, 1997 No Comments
RSS